Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Hodgkin lymphoma or non-Hodgkin lymphoma, confirmed by laboratory testing of tissue.
- People who are 20 years of age or older.
- People whose doctors have determined they need chemotherapy given throughout the body, with the goal of curing the disease.
- People who are able to provide written agreement to participate in the trial.
Who may not be able to join:
- People who have a type of blood cancer that affects the myeloid cells (a different type of blood cell).
- People who have multiple myeloma (a cancer of plasma cells in the bone marrow).
- People whose treatment does not involve chemotherapy given throughout the body with the goal of curing the disease.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Seok Jin Kim, MD, PhD, Samsung Medical Center
Phone: +82234101766
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Response rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.